Financial Network Wealth Advisors LLC Recursion Pharmaceuticals, Inc. Transaction History
Financial Network Wealth Advisors LLC
- $76.2 Billion
- Q1 2025
A detailed history of Financial Network Wealth Advisors LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Financial Network Wealth Advisors LLC holds 100 shares of RXRX stock, worth $408. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100Holding current value
$408% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding RXRX
# of Institutions
366Shares Held
286MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$142 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$132 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$99.5 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$70.6 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$59.8 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $736M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...